Amunix Pharmaceuticals
Mar 05, 2020
CAR-T in killing tumors; Amunix raises $73M; Autism findings in protein-targeted treatment
Killing brain tumors with the help of CAR-T CAR-T cell therapy is a technique which involves modifying patients' T cells to aim proteins associated with cancer that have revolutionized some of the blood cancers treatment. However, the technique has so far shown low potential in solid tumors like aggressive brain...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
